141 related articles for article (PubMed ID: 30875751)
1. 'Messy' Processing of χ-conotoxin MrIA Generates Homologues with Reduced hNET Potency.
Ziegman R; Brust A; Jha P; Cardoso FC; Lewis RJ; Alewood PF
Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30875751
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+ dependence, and structure-activity relationship.
Sharpe IA; Palant E; Schroeder CI; Kaye DM; Adams DJ; Alewood PF; Lewis RJ
J Biol Chem; 2003 Oct; 278(41):40317-23. PubMed ID: 12885787
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the norepinephrine transporter by χ-conotoxin dendrimers.
Wan J; Brust A; Bhola RF; Jha P; Mobli M; Lewis RJ; Christie MJ; Alewood PF
J Pept Sci; 2016 May; 22(5):280-9. PubMed ID: 26910400
[TBL] [Abstract][Full Text] [Related]
4. chi-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter.
Bryan-Lluka LJ; Bönisch H; Lewis RJ
J Biol Chem; 2003 Oct; 278(41):40324-9. PubMed ID: 12837768
[TBL] [Abstract][Full Text] [Related]
5. Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.
Lovelace ES; Armishaw CJ; Colgrave ML; Wahlstrom ME; Alewood PF; Daly NL; Craik DJ
J Med Chem; 2006 Nov; 49(22):6561-8. PubMed ID: 17064074
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of chi-conopeptide MrIA, a modulator of the human norepinephrine transporter.
Nilsson KP; Lovelace ES; Caesar CE; Tynngård N; Alewood PF; Johansson HM; Sharpe IA; Lewis RJ; Daly NL; Craik DJ
Biopolymers; 2005; 80(6):815-23. PubMed ID: 15931669
[TBL] [Abstract][Full Text] [Related]
7. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.
Brust A; Palant E; Croker DE; Colless B; Drinkwater R; Patterson B; Schroeder CI; Wilson D; Nielsen CK; Smith MT; Alewood D; Alewood PF; Lewis RJ
J Med Chem; 2009 Nov; 52(22):6991-7002. PubMed ID: 19860431
[TBL] [Abstract][Full Text] [Related]
8. Conus venom peptide pharmacology.
Lewis RJ; Dutertre S; Vetter I; Christie MJ
Pharmacol Rev; 2012 Apr; 64(2):259-98. PubMed ID: 22407615
[TBL] [Abstract][Full Text] [Related]
9. Comparative Venomics Reveals the Complex Prey Capture Strategy of the Piscivorous Cone Snail Conus catus.
Himaya SW; Jin AH; Dutertre S; Giacomotto J; Mohialdeen H; Vetter I; Alewood PF; Lewis RJ
J Proteome Res; 2015 Oct; 14(10):4372-81. PubMed ID: 26322961
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of the χ-conopeptide class of analgesic peptides.
Lewis RJ
Toxicon; 2012 Mar; 59(4):524-8. PubMed ID: 21839105
[TBL] [Abstract][Full Text] [Related]
11. Cone snail venomics: from novel biology to novel therapeutics.
Prashanth JR; Brust A; Jin AH; Alewood PF; Dutertre S; Lewis RJ
Future Med Chem; 2014 Oct; 6(15):1659-75. PubMed ID: 25406006
[TBL] [Abstract][Full Text] [Related]
12. High accuracy mass spectrometry comparison of Conus bandanus and Conus marmoreus venoms from the South Central Coast of Vietnam.
Nguyen B; Molgó J; Lamthanh H; Benoit E; Khuc TA; Ngo DN; Nguyen NT; Millares P; Le Caer JP
Toxicon; 2013 Dec; 75():148-59. PubMed ID: 23792454
[TBL] [Abstract][Full Text] [Related]
13. Novel Conopeptides of Largely Unexplored Indo Pacific Conus sp.
Lebbe EK; Ghequire MG; Peigneur S; Mille BG; Devi P; Ravichandran S; Waelkens E; D'Souza L; De Mot R; Tytgat J
Mar Drugs; 2016 Oct; 14(11):. PubMed ID: 27801785
[TBL] [Abstract][Full Text] [Related]
14. Engineering of conotoxins for the treatment of pain.
Carstens BB; Clark RJ; Daly NL; Harvey PJ; Kaas Q; Craik DJ
Curr Pharm Des; 2011 Dec; 17(38):4242-53. PubMed ID: 22204425
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new subclass of α-conotoxins in the venom of Conus australis.
Lebbe EK; Peigneur S; Maiti M; Mille BG; Devi P; Ravichandran S; Lescrinier E; Waelkens E; D'Souza L; Herdewijn P; Tytgat J
Toxicon; 2014 Dec; 91():145-54. PubMed ID: 25194747
[TBL] [Abstract][Full Text] [Related]
16. Pc16a, the first characterized peptide from Conus pictus venom, shows a novel disulfide connectivity.
Van Der Haegen A; Peigneur S; Dyubankova N; Möller C; Marí F; Diego-García E; Naudé R; Lescrinier E; Herdewijn P; Tytgat J
Peptides; 2012 Mar; 34(1):106-13. PubMed ID: 22079220
[TBL] [Abstract][Full Text] [Related]
17. The Venom Repertoire of Conus gloriamaris (Chemnitz, 1777), the Glory of the Sea.
Robinson SD; Li Q; Lu A; Bandyopadhyay PK; Yandell M; Olivera BM; Safavi-Hemami H
Mar Drugs; 2017 May; 15(5):. PubMed ID: 28531118
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of cone snail venom peptides (conopeptides).
Vetter I; Lewis RJ
Curr Top Med Chem; 2012; 12(14):1546-52. PubMed ID: 22827523
[TBL] [Abstract][Full Text] [Related]
19. Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter.
Sharpe IA; Gehrmann J; Loughnan ML; Thomas L; Adams DA; Atkins A; Palant E; Craik DJ; Adams DJ; Alewood PF; Lewis RJ
Nat Neurosci; 2001 Sep; 4(9):902-7. PubMed ID: 11528421
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic.
Gori A; Wang CI; Harvey PJ; Rosengren KJ; Bhola RF; Gelmi ML; Longhi R; Christie MJ; Lewis RJ; Alewood PF; Brust A
Angew Chem Int Ed Engl; 2015 Jan; 54(4):1361-4. PubMed ID: 25483297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
